蛋白质乙化和相关的潜在治疗策略在脏疾病
Xiang-Yu Li1, Ju-Tao Yu1, Yu-Hang Dong1
1Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Pharmacological research
|October 11, 2023
概括
表观遗传学,特别是乙化,在病中起着关键作用. 用新疗法向乙化通路为治疗脏疾病和改善治疗结果提供了潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 病是一个日益增长的全球健康挑战,预防治疗有限.
- 表观遗传修饰,特别是乙化,越来越多地被认为对功能和疾病的关键作用.
- 基因素乙转移酶 (HATs),基因素脱乙酶 (HDACs) 和乙化的读者是稳定的主要调节者.
研究的目的:
- 审查脏中乙化生理过程.
- 总结乙化影响病理的机制.
- 探索脏疾病中向乙化的治疗潜力.
主要方法:
- 关于乙化和病的最新研究的文献综述.
- 在生理学中分析HATs,HDACs和乙氨酸读取器的作用.
- 在病中检查乙化调节剂的证据.
主要成果:
- 乙化是脏生理恒温的组成部分.
- 异常乙化涉及到各种病的发病.
- 针对乙化的新兴抑制剂和激活剂在治疗脏疾病方面显示出有前途.
结论:
- 乙化是脏健康和疾病中的关键表观遗传机制.
- 向乙化通路代表了对病理的有前途的治疗策略.
- 对乙化调节剂的进一步研究可能会导致对病的有效治疗.
关键词:
C646 (PubChem CID: 1285941) 这是一本书.C66 (PubChem CID: 7315371) 这是一个很好的例子.库尔库 (PubChem CID: 969516) 是一种一种迪奥斯基宁 (PubChem CID: 99474) 是一种JQ1 (PubChem CID: 46907787) 这是一本书.脏疾病 脏疾病L002 (PubChem CID: 2221149) 这是一本书.液化基因因 (PubChem CID: 114829) 是一种化学物质.马特林 (PubChem CID: 91466) 是一个聚达丁 (PubChem CID: 71311798) 的使用情况可能的治疗策略.蛋白质乙化是蛋白质的乙化.复星 (PubChem CID: 445154) 是一种药物中的一种.萨哈 (PubChem CID: 5311) 是一个SRT-1720 (PubChem CID: 24180125) 这是一个非常简单的方法.沙利多化物 (PubChem CID: 159278) 是一种化物.萨尔维亚诺基酸B (PubChem CID: 6451084) 的使用情况四素化物 (PubChem CID: 82835) 是一种四化物.TMP195 (PubChem CID: 67324851) 是一个非常有价值的产品.TMP269 (PubChem CID: 53344908) 的使用情况在TSA (PubChem CID: 444732) 中使用.图巴辛 (PubChem CID: 6675804) 是一个在VPA (PubChem CID: 3121) 中使用.相关概念视频
Phase II Reactions: Acetylation Reactions
239
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
239
Acute Kidney Injury IV: Diagnostic Studies and Prevention
20
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
20
Chronic Kidney Disease III: Interprofessional Care
24
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
24
Acute Kidney Injury V: Interprofessional Care
11
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
11
Chronic Kidney Disease I: Introduction
18
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
18
Acute Kidney Injury VI: Nursing Management
17
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
17


